News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Chiesi and Gossamer Bio Collaborate Globally to Develop and Commercialize Seralutinib for Pulmonary Arterial Hypertension and Other Respiratory Disorders
Tuesday, May 07, 2024Chiesi Farmaceutici SpA also known as Chiesi Group and Gossamer Bio Inc a biopharmaceutical company focused on seralutinib for treating pulmonary hypertension have entered into a global
IRLAB Granted Approval by Swedish Medical Products Agency for Phase I Trial of IRL757 Drug Candidate
Monday, May 06, 2024IRLAB Therapeutics AB has recently received approval from the Swedish Medical Products Agency to commence a Phase I clinical trial for their potential treatment for Parkinsons disease
AMO Pharma Wraps Up FDA Consultation, Reveals Strategy for Advancing AMO-02 (tideglusib) in Myotonic Dystrophy Therapy
Friday, May 03, 2024AMO Pharma Limited a company specializing in rare genetic disorders has shared updates on its plans for advancing the development of AMO to treat Type myotonic dystrophy
Delphia Therapeutics Introduces a Novel Field in Cancer Medicine: Activation Lethality
Friday, May 03, 2024Delphia Therapeutics Inc unveiled its groundbreaking mission today to pioneer a fresh frontier in cancer biology called activation lethality aiming to exploit cancers unexpected susceptibility to oncogene
Creyon Bio and Cajal Neuroscience Enter Collaboration to Develop Oligonucleotide-Based Therapies for Neurodegenerative Conditions
Thursday, May 02, 2024Creyon Bio Inc and Cajal Neuroscience have recently announced a collaborative effort to develop innovative treatments for neurodegenerative diseases Creyon specializes
Scenic Biotech Partners with Bristol Myers Squibb for Research Collaboration
Thursday, May 02, 2024Scenic Biotech a leader in the field of modifier therapies for severe genetic disorders has announced a research collaboration with Bristol Myers Squibb aimed at accelerating the development of drug targets owned by Bristol Myers Squibb The collabora...
Medison Pharma and Alnylam Pharmaceuticals Expand Collaboration to Introduce RNAi Therapeutics in Additional LATAM and APAC Territories, Including Australia
Wednesday, May 01, 2024Medison Pharma and Alnylam Pharmaceuticals Inc have announced an expansion of their partnership
Caris Life Sciences and COTA, Inc. Team Up to Broaden Collective Multi-Modal Data Offerings
Wednesday, May 01, 2024Caris Life Sciences a leader in AI TechBio and precision medicine has partnered with COTA Inc an oncology realworld data and analytics firm to enhance their multimodal data offerings
Avenacy Launches Eptifibatide Injection in the U.S. Market
Tuesday, April 30, 2024Avenacy a pharmaceutical company specializing in critical injectable medications has introduced Eptifibatide for Injection in the United States This medication approved by the US Food and Drug Administration serves as a generic equivalent for Integri...
RenAgade Therapeutics expands its dedication to glycobiology through the establishment of GanNA Bio
Monday, April 29, 2024ReNAgade Therapeutics is broadening its scope in RNA medicine through a collaboration with GanNA Bio This partnership aims to explore the potential of glycobiology in therapeutic applications
